BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30552634)

  • 21. Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.
    Kanchanatawan B; Sirivichayakul S; Thika S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Noto C; Ivanova R; Maes M
    Metab Brain Dis; 2017 Aug; 32(4):1003-1016. PubMed ID: 28258445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach.
    Maes M; Sirivichayakul S; Matsumoto AK; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Barbosa DS; Carvalho AF; Solmi M; Kanchanatawan B
    Mol Neurobiol; 2020 Nov; 57(11):4578-4597. PubMed ID: 32754898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.
    Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Ormstad H; Anderson G; Maes M
    Mol Neurobiol; 2018 Feb; 55(2):1524-1536. PubMed ID: 28181189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The menstrual cycle may not be limited to the endometrium but also may impact gut permeability.
    Roomruangwong C; Carvalho AF; Geffard M; Maes M
    Acta Neuropsychiatr; 2019 Dec; 31(6):294-304. PubMed ID: 31364524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia.
    Kanchanatawan B; Sriswasdi S; Maes M
    Metab Brain Dis; 2019 Feb; 34(1):267-282. PubMed ID: 30467771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficit schizophrenia and its features are associated with PON1 Q192R genotypes and lowered paraoxonase 1 (PON1) enzymatic activity: effects on bacterial translocation.
    Matsumoto AK; Maes M; Supasitthumrong T; Maes A; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Kanchanatawan B; Barbosa DS
    CNS Spectr; 2021 Aug; 26(4):406-415. PubMed ID: 32638685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome.
    Maes M; Leunis JC
    Neuro Endocrinol Lett; 2014; 35(7):577-85. PubMed ID: 25617880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study.
    Kanchanatawan B; Thika S; Sirivichayakul S; Carvalho AF; Geffard M; Maes M
    Neurotox Res; 2018 Apr; 33(3):641-655. PubMed ID: 29380275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde.
    Maes M; Sirivichayakul S; Kanchanatawan B; Carvalho AF
    World J Biol Psychiatry; 2020 Jun; 21(5):383-401. PubMed ID: 32031479
    [No Abstract]   [Full Text] [Related]  

  • 30. Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: Results of unsupervised machine learning analysis.
    Kanchanatawan B; Sriswasdi S; Thika S; Stoyanov D; Sirivichayakul S; Carvalho AF; Geffard M; Maes M
    J Eval Clin Pract; 2018 Aug; 24(4):879-891. PubMed ID: 29790237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.
    Maes M; Leunis JC; Geffard M; Berk M
    Neuro Endocrinol Lett; 2014; 35(6):445-53. PubMed ID: 25433843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognizing the Leaky Gut as a Trans-diagnostic Target for Neuroimmune Disorders Using Clinical Chemistry and Molecular Immunology Assays.
    Simeonova D; Ivanovska M; Murdjeva M; Carvalho AF; Maes M
    Curr Top Med Chem; 2018; 18(19):1641-1655. PubMed ID: 30430944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compensatory IgM to the Rescue: Patients with Selective IgA Deficiency Have Increased Natural IgM Antibodies to MAA-LDL and No Changes in Oral Microbiota.
    Mella MA; Lavrinienko A; Akhi R; Hindström R; Nissinen AE; Wang C; Kullaa A; Salo T; Auvinen J; Koskimäki JJ; Hörkkö S
    Immunohorizons; 2021 Apr; 5(4):170-181. PubMed ID: 33893180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of the nitrosylome in bipolar disorder type 1 (BP1) and major depression, but not BP2: Increased IgM antibodies to nitrosylated conjugates are associated with indicants of leaky gut.
    Maes M; Simeonova D; Stoyanov D; Leunis JC
    Nitric Oxide; 2019 Oct; 91():67-76. PubMed ID: 31323278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome.
    Maes M; Twisk FN; Kubera M; Ringel K; Leunis JC; Geffard M
    J Affect Disord; 2012 Feb; 136(3):909-17. PubMed ID: 21967891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B1 cells contribute to serum IgM, but not to intestinal IgA, production in gnotobiotic Ig allotype chimeric mice.
    Thurnheer MC; Zuercher AW; Cebra JJ; Bos NA
    J Immunol; 2003 May; 170(9):4564-71. PubMed ID: 12707334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural regulatory IgM-mediated autoimmune responses directed against malondialdehyde regulate oxidative and nitrosative pathways and coupled with IgM responses to nitroso adducts attenuate depressive and physiosomatic symptoms at the end of term pregnancy.
    Roomruangwong C; Barbosa DS; de Farias CC; Matsumoto AK; Baltus THL; Morelli NR; Kanchanatawan B; Duleu S; Geffard M; Maes M
    Psychiatry Clin Neurosci; 2018 Feb; 72(2):116-130. PubMed ID: 29194848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions.
    Sirivichayakul S; Kanchanatawan B; Thika S; Carvalho AF; Maes M
    CNS Neurol Disord Drug Targets; 2019; 18(2):124-140. PubMed ID: 30451122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study.
    Al-Hakeim HK; Almulla AF; Maes M
    Neurotox Res; 2020 Mar; 37(3):753-771. PubMed ID: 31916129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome.
    Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
    Mol Neurobiol; 2017 May; 54(4):3038-3049. PubMed ID: 27037573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.